Navigation Links
NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Date:9/21/2007

SAN CARLOS, Calif., Sept. 21 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that it has completed enrollment in study C119, a second Phase 3 clinical trial of its lead product candidate NGX-4010 for the treatment of painful HIV-distal sensory polyneuropathy (HIV-DSP). NGX-4010 is a dermal patch designed to manage peripheral neuropathic pain. Previously completed Phase 3 trials demonstrated that a single, 30- or 60-minute treatment with NGX-4010 applied directly to the site of pain may provide pain relief for up to three months. C119 is a randomized, double-blind, controlled study that has enrolled over 480 patients at study sites in the United States, the United Kingdom, Australia and Canada.

"We believe that completion of enrollment in our C119 study marks a significant milestone in our NGX-4010 development program in HIV-DSP. We are currently in the follow-up phase of the study and expect to be able to provide top-line results near the end of the first quarter of 2008," commented Dr. Jeffery Tobias, Chief Medical Officer. "HIV-DSP is an important and underserved problem in patients with HIV/AIDS. There are currently no approved therapies for this indication. With the completion of enrollment in study C119, we are moving closer to our goal of providing an effective treatment for this patient population."

The study protocol for study C119 evaluates the effect of a single, 30- or 60-minute treatment with NGX-4010 or a low-concentration control patch applied directly to the patient's site of pain. NGX-4010 is administered by a physician during an in-office procedure. After 30 or 60 minutes, the study patch is removed and the patient's response to treatment is evaluated during the su
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
8. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N, Fla., Nov. 25 Ameri...("the Company") is pleased to announce that they h...agement office in Shanghai, China. ,, ASR has b... essential gateway for the development and product...ts for children and adults to be distributed and s...
(Date:11/25/2009)...ADELPHIA, Nov. 25 ERT (N.... McKelvey, the Company,s President and CEO, and K...nt and CFO, are scheduled to present at the 21st A... PM EST on December 1, 2009 in New York City, New ...entation by visiting the Company,s corporate websi...
(Date:11/25/2009)...LM BEACH, Fla., Nov. 25 ...cans, especially the 27 million living with untrea...at happy, says audiologist Cindy Beyer. ,, Dr. ...R ), one of America,s largest hearing care and he...aring loss to stress, frustration, and social isol...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3INHS Brings Health Information Technology Conference to Spokane 52550 1INHS Brings Health Information Technology Conference to Spokane 52550 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 1Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 3Risky driving puts P platers at high danger of crash 52541 1Risky driving puts P platers at high danger of crash 52541 2
...aceuticals,Inc. (Nasdaq: ARNA ) announced today t...e overview of its clinical development and discove... -- ThinkEquity Partners, 5th Annual Growth Confe... at 10:00 a.m. Pacific Time (1:00 p.m. Eastern... Presenting: Jack Lief, Arena,s President and Chie...
... Liver Cancer Conference Sta...y Consulting Firm Retained, NOVATO, Calif., Sept.... "Company") (OTC Bulletin Board:,RPTP.OB) announce...Scientific Officer, will present a poster detailin...al studies of its HepTide(TM) liver targeting,prog...
Other Medicine Technology:Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 3Raptor Pharmaceuticals Provides Update of Product Programs 2Raptor Pharmaceuticals Provides Update of Product Programs 3Raptor Pharmaceuticals Provides Update of Product Programs 4Raptor Pharmaceuticals Provides Update of Product Programs 5Raptor Pharmaceuticals Provides Update of Product Programs 6
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... Nov. 27 The diabetes population i...xt 25 years and annual medical spending on the dis...3 billion today, according to a study published in...nal Changing Diabetes ® Program (NCDP), a pr...y a team from the University of Chicago. ,, Acc...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)...f., Nov. 25 Onyx Pharm...that the company will host two investor events in ... 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ,, Prin...s surrounding carfilzomib in relapsed and/or refra...erican Society of Hematology (ASH) Annual Meeting ...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...NEW YORK, Jan. 25 Weight Watchers,International, ...hhoff,President and Chief Executive Officer, and A...at the Credit Suisse 10th Annual Global Services,C...accessible via live,audio webcast on the Company,s...
...ENGLEWOOD, Colo., Jan. 25 Baxa Corporation announ...the dedication of infusion,nurses to advancing the...g,research and education in their practice and con...-- January 25, 2008 --,infusion nurses will join t...
...First-Ever Online Video Contest Celebrates America...ves to Support Their Hometown Facilities, MALVERN... the Siemens "Win an MRI" contest is Lockport Memo...sonance,imaging (MRI) technology, brought to marke...
...EAST AURORA, N.Y., Jan. 25 Moog Inc. (NYSE:,MOG.A... of $27.7 million,and earnings per share of $.64, ... Sales of $446 million were up 25% from the year p... came in,both military and commercial programs. Mi...
...POWAY, Calif., Jan. 25 Digirad Corporation,(Nasda...ic imaging systems,and services to physicians, off... its latest work-in-progress during ACC.08, the Am...TM), a dedicated cardiac SPECT system, is,expected...
...WASHINGTON, Jan. 24 Karen Ignagni, President,and ...ued a statement on,the Institute of Medicine,s (IO...t would evaluate the effectiveness of healthcare p...work, but,which treatments work best. With new tre...
Other Medicine News:Health News:Weight Watchers to Present at Credit Suisse 10th Annual Global Services Conference 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 3Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 2Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 3Health News:Moog Reports 14% Increase in Earnings Per Share 2Health News:Moog Reports 14% Increase in Earnings Per Share 3Health News:Moog Reports 14% Increase in Earnings Per Share 4Health News:Moog Reports 14% Increase in Earnings Per Share 5Health News:Moog Reports 14% Increase in Earnings Per Share 6Health News:Moog Reports 14% Increase in Earnings Per Share 7Health News:Moog Reports 14% Increase in Earnings Per Share 8Health News:Digirad to Introduce New Clinical Standard for Cardiac SPECT 2Health News:Digirad to Introduce New Clinical Standard for Cardiac SPECT 3
VersaStep™ SHORT Reposable (Reusable Components - Short Length)
VERSASTEP™ Reposable Single Use Instruments
VersaStep™ Plus Instrument
...Open-Step™ single-use system device is compr...nents for creating each access port are also packa...cking cone with 12 mm Step™ cannula assembly...ocking cone with 10/12 mm Reposable Step™ va...
Medicine Products: